Replay available

West Pharmaceutical Services, Inc. (WST) Q1 2025 Earnings Call

West Pharmaceutical Services, Inc. (NYSE: WST) Q1 2025 earnings conference call, held 2025-04-24. Replay captured from the company's public earnings webcast.

Thu, April 24, 2025 at 9:00 AMendedReplay
West Pharmaceutical Services, Inc. (WST) Q1 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

John Sweeney

Vice President of Investor Relations

Eric Green

Chief Executive Officer

Bernard Berner

Chief Financial Officer

Paul Knight

Analyst, KeyBank

Larry Solo

Analyst, CJS Securities

Justin Bowers

Analyst, Deutsche Bank

Michael Ricekin

Analyst, Bank of America

David Windley

Analyst, Jefferies

Daniel Markowitz

Analyst, Evercore ISI

Thomas DeBorsy

Analyst, Nefron Research

Doug Schenkel

Analyst, Wolf Research

Mac Etosh

Analyst, Stevens

Patrick Donnelly

Analyst, Citi

Matt LaRue

Analyst, William Blair

Kyle Cruz

Analyst, UBS

Unknown Speaker

Unidentified/Intermittent Commentator

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the West Pharmaceutical Services first quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1 1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1-1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, John Sweeney, Vice President of Investor Relations. Please go ahead. Good morning and welcome to West's first quarter 2025 earnings conference call. We issued our financial results early this morning, and the release has been posted in the investor section of the company's website located at westfarmer.com. On the call today, we will review our financial results, provide an update for our business, and present our financial outlook for FY25. There's a slide presentation that accompanies today's call, and a copy of the presentation is available on the investor page of West's website. On slide four, there's a safe harbor statement, and statements made by management of the call and in the accompanying presentation contain forward-looking statements from the meaning of the U.S. federal securities law. These statements are based on our beliefs and assumptions, current expectations, estimates, and forecasts. The company's future results are influenced by many factors beyond the control of the company. Actual results could differ materially from past results, as well as those expressed or implied in any forward-looking statements made here. Please refer to today's press relea...

More from West Pharmaceutical Services, Inc.